OLAGUNJU PETER (Chief Technical Officer) sold 3.6% of their position (1.27K shares) of TCR2 THERAPEUTICS INC. on the open market
Open‑market sale worth $1.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2022ACC: 0001209191-22-059882
Officer· Chief Technical Officer
Since Jul 2021
+65.55K
Net shares
Net buyer
$1.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
66.82K acquired · 1.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+33.41K
Price / share
—
Trade value
—
% of position
1524.1%
12/1/2022
2.19K→35.60K
Common Stock
Direct
Shares
−1.27K
Price / share
$1.39
Trade value
$1.77K
% of position
3.6%
12/2/2022
35.60K→34.33K
Total
Net shares
+32.14K
Net value
-$1.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2022 | M · Option Exercise | +33.41K | — | — | 1524.1% | 2.19K | 35.60K |
| Common Stock Direct | 12/2/2022 | S · Sale | −1.27K | $1.39 | $1.77K | 3.6% | 35.60K | 34.33K |
| Total | +32.14K | -$1.77K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
33.41K shares
Shares
+33.41K
Strike price
Held after
62.05K
Exercisable
—
12/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock33.41K shares | 12/1/2022 | M · Option Exercise | +33.41K | — | 62.05K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned2.19K
Total
2.19K direct2.19K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.19K | Direct |
| Total | 2.19K | 2.19K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported